ASX - By Stock
|
IMC |
Re:
Ann: Immuron Travelan sales continued strong growth
|
|
Misterf
|
11 |
2.9K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
11
|
2.9K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Misterf
|
164 |
45K |
4 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
164
|
45K
|
4
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Capital Raising Presentation
|
|
Misterf
|
28 |
8.4K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
28
|
8.4K
|
1
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Capital Raising Presentation
|
|
Misterf
|
28 |
8.4K |
1 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
28
|
8.4K
|
1
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Capital Raising Presentation
|
|
Misterf
|
28 |
8.4K |
0 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
28
|
8.4K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Capital Raising Presentation
|
|
Misterf
|
28 |
8.4K |
0 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
28
|
8.4K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Capital Raising Presentation
|
|
Misterf
|
28 |
8.4K |
0 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
28
|
8.4K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
Misterf
|
14 |
4.2K |
0 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
14
|
4.2K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
Misterf
|
14 |
4.2K |
1 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
14
|
4.2K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Misterf
|
7 |
1.4K |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
7
|
1.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Misterf
|
7 |
1.4K |
1 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
7
|
1.4K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO, Steven Lydeamore to present at AusBioInvest
|
|
Misterf
|
9 |
2.3K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
9
|
2.3K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
Misterf
|
37 |
9.7K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
37
|
9.7K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron achieves record monthly Travelan sales
|
|
Misterf
|
33 |
7.5K |
0 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
33
|
7.5K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron achieves record monthly Travelan sales
|
|
Misterf
|
33 |
7.5K |
0 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
33
|
7.5K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
News: GSS Genetic Signatures Says 510(K) Application Submitted To US FDA
|
|
Misterf
|
5 |
2.5K |
0 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
5
|
2.5K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
News: GSS Genetic Signatures Says 510(K) Application Submitted To US FDA
|
|
Misterf
|
5 |
2.5K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
5
|
2.5K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron present to Military Health System Research Symposium
|
|
Misterf
|
13 |
4.2K |
0 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
13
|
4.2K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Says FY23 Sales Increase 136% On Fy22 Sales
|
|
Misterf
|
7 |
2.3K |
0 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
Misterf
|
22 |
8.4K |
0 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
22
|
8.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
|
|
Misterf
|
51 |
13K |
3 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
51
|
13K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
|
|
Misterf
|
51 |
13K |
0 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
51
|
13K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
|
|
Misterf
|
51 |
13K |
0 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
51
|
13K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Innovation steven
|
|
Misterf
|
4 |
1.0K |
0 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
4
|
1.0K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Business Update Presentation
|
|
Misterf
|
43 |
13K |
1 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
43
|
13K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Business Update Presentation
|
|
Misterf
|
43 |
13K |
0 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
43
|
13K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Business Update Presentation
|
|
Misterf
|
43 |
13K |
0 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
43
|
13K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore to host investor webinar
|
|
Misterf
|
9 |
2.9K |
1 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
9
|
2.9K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore to host investor webinar
|
|
Misterf
|
9 |
2.9K |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
9
|
2.9K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: US DOD Travelan Clinical Recruitment Milestone
|
|
Misterf
|
12 |
3.1K |
0 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
12
|
3.1K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: US DOD Travelan Clinical Recruitment Milestone
|
|
Misterf
|
12 |
3.1K |
2 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
12
|
3.1K
|
2
|
|
ASX - By Stock
|
GSS |
Re:
GSS
|
|
Misterf
|
7 |
2.4K |
2 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
7
|
2.4K
|
2
|
|
ASX - By Stock
|
GSS |
Re:
GSS
|
|
Misterf
|
7 |
2.4K |
1 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
7
|
2.4K
|
1
|
|
ASX - By Stock
|
GSS |
Re:
GSS
|
|
Misterf
|
7 |
2.4K |
1 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
7
|
2.4K
|
1
|
|
ASX - By Stock
|
GSS |
GSS
|
|
Misterf
|
7 |
2.4K |
0 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
7
|
2.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
European patent granted for c.diff
|
|
Misterf
|
14 |
5.3K |
0 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
14
|
5.3K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
European patent granted for c.diff
|
|
Misterf
|
14 |
5.3K |
0 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
14
|
5.3K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Receives FDA Approval for Travelan IND Application
|
|
Misterf
|
53 |
16K |
2 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
53
|
16K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Update on IND Application for Campylobacter ETEC Therapeutic
|
|
Misterf
|
10 |
4.1K |
4 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
10
|
4.1K
|
4
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
Misterf
|
13 |
5.9K |
1 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
13
|
5.9K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
C.Diff
|
|
Misterf
|
8 |
1.9K |
0 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
8
|
1.9K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore to present at AusBioInvest
|
|
Misterf
|
17 |
4.6K |
2 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
17
|
4.6K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore to present at AusBioInvest
|
|
Misterf
|
17 |
4.6K |
2 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
17
|
4.6K
|
2
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Misterf
|
2 |
783 |
1 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
2
|
783
|
1
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Strategic Investment In Leading Gut Health Biotech Ateria Health
|
|
Misterf
|
5 |
2.4K |
3 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
5
|
2.4K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Says Signed Subscription And Option Agreement With Gut Health Biotech Ateria...
|
|
Misterf
|
4 |
1.8K |
2 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
4
|
1.8K
|
2
|
|
ASX - By Stock
|
IMC Lifestyle |
Re:
Marketing Products
|
|
Misterf
|
9 |
16K |
3 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
9
|
16K
|
3
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Appendix 4G and Corporate Governance Statement
|
|
Misterf
|
1 |
577 |
3 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
1
|
577
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Annual Report to shareholders
|
|
Misterf
|
18 |
5.4K |
5 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
18
|
5.4K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Annual Report to shareholders
|
|
Misterf
|
18 |
5.4K |
2 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
18
|
5.4K
|
2
|
|